Global Hematology Market - Segmented by Product, Reagent, Application, End-users, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • ID: 4591343
  • Report
  • Region: Global
  • 112 pages
  • Mordor Intelligence
until Dec 31st 2018
1 of 5


  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Dolomite Centre
  • F. Hoffmann-La Roche Ag
  • MORE
The Hematology Market is expected to register a CAGR of about 5%, during the forecast period, 2018 to 2023. Hematology market is set to witness growth in the forecasted instruments are emerging as vital diagnostic tools used in testing, counting, measuring, and analyzing red blood cells, WBC, and platelets. Hematology instruments have witnessed significant changes in design over the years and have evolved rapidly from traditional instruments to present day, automated instruments that provide fast and accurate results. Automation is a recent trend in the hematology instruments market.

Increasing Incidences of Blood Disorders

The incidences of blood-related disorders are increasing rapidly globally. Approximately one person is diagnosed with blood cancer every 3 minutes in the US. Serious blood disorders, which might lead to the use of hematology include anemia, malaria, thalassemia, myelodysplastic syndrome, etc. Along with this, the rising incidence of kidney diseases is expected to induce huge growth in the hematology market. Also, with this other factors, such as rapid technological advances and emergence of high throughput hematology analyzers are boosting the market growth.

Low Adoption of Hematology Analyzers in Emerging Economies

Hematology analyzers are large automated integrated systems that combine all forms of sample processing, analysis, and presentation of results. They also help in pre and post-analytical sample handling and management of reagent supply with limited user interference. These systems help laboratories generate results in faster turnaround time, thereby improving the efficiency and labor utilization. These instruments are expensive capital equipment and emerging economies are largely unable to afford them in spite of the ease at which the results are rendered, and the accuracy of the results hematology analyzers provide. This acts as a restraint for the growth of the hematology market. The high cost of equipment and reagents along with poor health insurance coverage slow down the growth of the hematology market.

North to Witness Considerable Growth in the Forecast Period

North America is currently the largest market for hematology analyzers. This market trend can be attributed to the increasing incidence of blood disorders. More and more cases of blood-related disorders, such as anemia, blood cancer, etc. will lead to the growth of the market of hematology. Europe is the second-largest market while Asia-Pacific is the fastest growing region.

Key Developments in the Market
  • November 2017 - Sysmex Acquired CLIA Waiver for New Automated Hematology Analyzer—The First Automated Hematology Analyzer to Receive Such Approval

Reasons to Purchase this Report
  • Current and future Hematology Market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
Note: Product cover images may vary from those shown
2 of 5


  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Dolomite Centre
  • F. Hoffmann-La Roche Ag
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Incidences of Blood Disorders and Other Diseases
6.1.2 Rapid Technological Advances in Hematology
6.1.3 Emergence of High Throughput Hematology Analyzers
6.2 Market Restraints
6.2.1 High Cost of the Instruments
6.2.2 Poor Health Insurance Coverage
6.2.3 Low Adoption of Hematology Analyzers in Emerging Economies

7. Market Segmentation
7.1 By Product
7.1.1 Hematology Analyzers
7.1.2 Flow Cytometers
7.1.3 Coagulation Analyzers
7.1.4 Slide Stainers
7.1.5 Centrifuges
7.1.6 Hemoglobinometers
7.1.7 Others
7.2 By Reagent
7.2.1 Coagulation Reagents
7.2.2 Flow Cytometery Reagents
7.2.3 Immuno-Hematology Reagents
7.2.4 Others
7.3 By Application
7.3.1 Drug Testing
7.3.2 Auto Immune Disease
7.3.3 Cancer
7.3.4 Diabetes Mellitus
7.3.5 Infectious Disease
7.3.6 Others
7.4 By End-users
7.4.1 Hospitals
7.4.2 Clinical Testing Institutes
7.4.3 Patient Self-testing
7.4.4 Others
7.5 By Geography
7.5.1 North America United States Canada Mexico
7.5.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
7.5.3 Asia-Pacific China Japan India Australia & New Zealand South Korea Rest of Asia-Pacific
7.5.4 Middle East & Africa GCC South Africa Rest of the Middle East & Africa
7.5.5 South America Brazil Argentina Rest of South America

8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches

9. Key Players
9.1 Abbott Laboratories
9.2 Agilent Technologies Inc.
9.3 Bio-Rad Laboratories Inc.
9.4 Danaher Corporation
9.5 Dolomite Centre
9.6 F. Hoffmann-La Roche AG
9.7 Fluidigm Corporation
9.8 Micronit Microfluidics BV
9.9 PerkinElmer Inc.
9.10 Thermo Fisher Scientific Inc.
9.11 uFluidix
9.12 List Not Exhaustive

10. Future of the Market
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Dolomite Centre
  • F. Hoffmann-La Roche Ag
  • Fluidigm Corporation
  • Micronit Microfluidics Bv
  • Perkinelmer Inc.
  • Thermo Fisher Scientific Inc.
  • Ufluidix
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown